Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Goodwin, 2006, Energy balance and cancer prognosis: breast cancer, 405
Goodwin, 2002, Fasting insulin and outcome in early stage breast cancer: results of a prospective cohort study, J Clin Oncol, 20, 42, 10.1200/JCO.20.1.42
Borugian, 2004, Insulin, macronutrient intake, and physical activity: Are potential indicators of insulin resistance associated with mortality from breast cancer?, Cancer Epidemiol Biomarkers Prev, 13, 1163, 10.1158/1055-9965.1163.13.7
Pollak, 2006, Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA.14 adjuvant breast cancer trial, J Clin Oncol, 24, 9s
Pasanisi, 2006, Metabolic syndrome as a prognostic factor for breast cancer recurrences, Int J Cancer, 119, 236, 10.1002/ijc.21812
Reaven, 2005, The insulin resistance syndrome: definition and dietary approaches to treatment, Ann Rev Nutr, 25, 391, 10.1146/annurev.nutr.24.012003.132155
Blackburn, 2006, Obesity and insulin resistance, 301
Frasca, 2003, Insulin and hybrid/IGF receptors are major regulators of breast cancer cells, Breast Dis, 17, 73, 10.3233/BD-2003-17108
Mulligan, 2007, Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer, Breast Cancer Res Treat, 106, 39, 10.1007/s10549-006-9471-x
Raptis, 2001, Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers, Exp Clin Endocrinol Diabetes, 109, S265, 10.1055/s-2001-18588
Hällsten, 2002, Rosiglitazone but not metformin enhances insulin-and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes, Diabetes, 51, 3479, 10.2337/diabetes.51.12.3479
Virtanen, 2003, Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects, Diabetes, 52, 283, 10.2337/diabetes.52.2.283
Shaw, 2005, The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin, Science, 310, 1642, 10.1126/science.1120781
Marx, 2005, Medicine. Cancer-suppressing enzyme adds a link to type 2 diabetes, Science, 310, 1259, 10.1126/science.310.5752.1259a
Evans, 2005, Metformin and reduced risk of cancer in diabetic patients, BMJ, 330, 1304, 10.1136/bmj.38415.708634.F7
Bowker, 2006, Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin, Diabetes Care, 29, 254, 10.2337/diacare.29.02.06.dc05-1558
Jiralerspong, 2008, The effects of metformin on pathologic complete response (pCR) rates in diabetic breast cancer (BC) patients receiving neoadjuvant therapy (NST), J Clin Oncol, 26, 13s
Anisimov, 2005, Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice, Exp Gerontol, 40, 685, 10.1016/j.exger.2005.07.007
Anisimov, 2005, Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice, Bull Exp Biol Med, 139, 721, 10.1007/s10517-005-0389-9
Wallace, 2004, The assessment of insulin resistance in man, Diabetes Med, 19, 527, 10.1046/j.1464-5491.2002.00745.x
Bonora, 2000, Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity, Diabetes Care, 23, 57, 10.2337/diacare.23.1.57
Glucophage (metformin hydrochloride) [product monograph]. Sanofi-aventis Canada, Inc., Version 2.0, June 20, 2006.
Chlebowski, 2006, Dietary fat reduction and breast cancer outcomes: interim efficacy results from the Women's Intervention Nutrition Study, J Natl Cancer Inst, 98, 1767, 10.1093/jnci/djj494
Pierce, 2007, Influence of a diet very high in vegetables, fruits and fiber and low in fat on prognosis following treatment for breast cancer; the Women's Healthy Eating and Living (WHEL) randomized trial, JAMA, 298, 289, 10.1001/jama.298.3.289
Zakikhani, 2006, Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells, Cancer Res, 66, 10269, 10.1158/0008-5472.CAN-06-1500
Dowling, 2007, Metformin inhibitis mammalian target of rapamycin-dependent translation initiation in breast cancer cells, Cancer Res, 67, 10804, 10.1158/0008-5472.CAN-07-2310
Goodwin, 2008, Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?, J Clin Oncol, 26, 833, 10.1200/JCO.2007.14.7132